Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2018, we are an international leader in the development of in-vivo biomarkers to guide targeted therapies in oncology.We develop in-vivo biomarkers transforming oncology, guiding treatment selection and monitoring, improving patients’ pathway and quality of life. ​Within a Positron Emission Tomography exam (PET Scan), biomarkers help oncologists and nuclear medicine physicians personalize the treatment, based on...
Founded in 2018, we are an international leader in the development of in-vivo biomarkers to guide targeted therapies in oncology.We develop in-vivo biomarkers transforming oncology, guiding treatment selection and monitoring, improving patients’ pathway and quality of life. ​Within a Positron Emission Tomography exam (PET Scan), biomarkers help oncologists and nuclear medicine physicians personalize the treatment, based on whole body imaging providing the localization and characteristics of tumors.

List your booth number for exhibitions, ask us